Get access

Long-term outcomes for the endoscopic modified lothrop/draf III procedure: A 10-year review

Authors

  • Yuresh Naidoo BE, MBBS,

    1. Department of Surgery–Otolaryngology Head and Neck Surgery, University of Adelaide, Adelaide, South Australia, Australia
    Search for more papers by this author
  • Ahmed Bassiouni MBBS,

    1. Department of Surgery–Otolaryngology Head and Neck Surgery, University of Adelaide, Adelaide, South Australia, Australia
    Search for more papers by this author
  • Mark Keen MBBS,

    1. Department of Surgery–Otolaryngology Head and Neck Surgery, University of Adelaide, Adelaide, South Australia, Australia
    Search for more papers by this author
  • Peter J. Wormald MD, FRACS

    Corresponding author
    1. Department of Surgery–Otolaryngology Head and Neck Surgery, University of Adelaide, Adelaide, South Australia, Australia
    • Send correspondence to Peter J. Wormald, MD, Chairman and Head, Department of Otolaryngology–Head and Neck Surgery, The University of Adelaide, Adelaide, South Australia, Australia 5005. E-mail: peterj.wormald@adelaide.edu.au

    Search for more papers by this author

  • Peter J. Wormald, MD, receives royalties from Medtronic ENT and is a consultant for NeilMed.

  • The authors have no other funding, financial relationships, or conflicts of interest to disclose.

Abstract

Objectives/Hypothesis

To detail the long-term outcomes of the endoscopic modified Lothrop procedure (EMLP) (also know as Draf III/frontal drillout) and identify key risk factors for failure.

Study Design

Retrospective cohort study and chart review.

Methods

Endoscopic assessment of frontal ostium patency and patient-reported symptoms were prospectively collected on patients who underwent EMLP between January 2001 and December 2011 for chronic rhinosinusitis (CRS). Risk factors for failing EMLP were identified.

Results

There were 229 patients who met the inclusion and exclusion criteria and underwent an EMLP. The average number of standard endoscopic sinus surgery procedures prior to an EMLP was 3.8 (95% confidence interval [CI]: 3.4-4.2, standard deviation [SD]: 3.3).The average length of follow-up was 45.0 months (95% CI: 41.2–48.9 months, SD: 22.3 months). The EMLP was successful in 95% (217/229), with no further surgery being required. Postsurgical recurrence of disease with persistence of symptoms requiring revision EMLP occurred in 12 patients. No complications were identified. Allergic fungal sinusitis and recurrent Staphylococcus aureus infections were identified as potential risk factors for failure.

Conclusions

This is the single largest study of EMLP in the literature with a long follow-up period. It illustrates the benefit of the EMLP for patients with CRS recalcitrant to medical and standard endoscopic sinus surgery.

Level of Evidence

4 Laryngoscope, 124:43–49, 2014

Ancillary